Skip to content

Clinical trials

Completed Phase 1 Lymphoma, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Phase: Phase 1 Status: Completed Clear all

97 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20064
20074
20083
20091
20103
20113
20124
20137
20143
20152
20169
20178
20188
20197
202014
20215
20221
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed97

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)10
Pfizer3
AstraZeneca2
Calibr, a division of Scripps Research2
Hoffmann-La Roche2
M.D. Anderson Cancer Center2
Mayo Clinic2
Peking Union Medical College Hospital2
Pharmacyclics LLC.2
Seagen Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell97
Lymphoma, Non-Hodgkin25
Lymphoma21
Lymphoma, Follicular20
Leukemia, Lymphocytic, Chronic, B-Cell18
Lymphoma, Mantle-Cell17
Lymphoma, B-Cell, Marginal Zone13
Lymphoma, Large B-Cell, Diffuse13
Burkitt Lymphoma11
Waldenstrom Macroglobulinemia10

Trials

Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.